186 related articles for article (PubMed ID: 36889924)
1. Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study.
Fisch U; Jünger AL; Baumann SM; Semmlack S; De Marchis GM; Hunziker S; Rüegg S; Marsch S; Sutter R
Neurology; 2023 May; 100(19):e1955-e1966. PubMed ID: 36889924
[TBL] [Abstract][Full Text] [Related]
2. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
[TBL] [Abstract][Full Text] [Related]
3. EEG Characteristics of Successful Burst Suppression for Refractory Status Epilepticus.
Johnson EL; Martinez NC; Ritzl EK
Neurocrit Care; 2016 Dec; 25(3):407-414. PubMed ID: 27406818
[TBL] [Abstract][Full Text] [Related]
4. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
Rossetti AO; Logroscino G; Bromfield EB
Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus.
Arya R; Peariso K; Gaínza-Lein M; Harvey J; Bergin A; Brenton JN; Burrows BT; Glauser T; Goodkin HP; Lai YC; Mikati MA; Fernández IS; Tchapyjnikov D; Wilfong AA; Williams K; Loddenkemper T;
Epilepsy Res; 2018 Aug; 144():1-6. PubMed ID: 29727818
[TBL] [Abstract][Full Text] [Related]
6. Variability in pharmacologically-induced coma for treatment of refractory status epilepticus.
An J; Jonnalagadda D; Moura V; Purdon PL; Brown EN; Westover MB
PLoS One; 2018; 13(10):e0205789. PubMed ID: 30379935
[TBL] [Abstract][Full Text] [Related]
7. Does burst-suppression achieve seizure control in refractory status epilepticus?
Phabphal K; Chisurajinda S; Somboon T; Unwongse K; Geater A
BMC Neurol; 2018 Apr; 18(1):46. PubMed ID: 29679985
[TBL] [Abstract][Full Text] [Related]
8. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus.
Kang BS; Jung KH; Shin JW; Moon JS; Byun JI; Lim JA; Moon HJ; Kim YS; Lee ST; Chu K; Lee SK
J Clin Neurosci; 2015 May; 22(5):854-8. PubMed ID: 25744078
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
10. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
Stetefeld HR; Schaal A; Scheibe F; Nichtweiß J; Lehmann F; Müller M; Gerner ST; Huttner HB; Luger S; Fuhrer H; Bösel J; Schönenberger S; Dimitriadis K; Neumann B; Fuchs K; Fink GR; Malter MP;
Neurocrit Care; 2021 Dec; 35(3):631-639. PubMed ID: 34286464
[TBL] [Abstract][Full Text] [Related]
11. Balancing the risks and benefits of anesthetics in status epilepticus.
Sutter R; Jünger AL; Baumann SM; Grzonka P; De Stefano P; Fisch U
Epilepsy Behav; 2023 Jan; 138():109027. PubMed ID: 36496337
[TBL] [Abstract][Full Text] [Related]
12. Association Between Dose Escalation of Anesthetics and Outcomes in Patients With Refractory Status Epilepticus.
Fisch U; Jünger AL; Baumann SM; Semmlack S; De Marchis GM; Rüegg SJ; Hunziker S; Marsch S; Sutter R
Neurology; 2024 Jan; 102(2):e207995. PubMed ID: 38165316
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Refractory Status Epilepticus With Continuous Intravenous Anesthetic Drugs: A Systematic Review.
Au YK; Kananeh MF; Rahangdale R; Moore TE; Panza GA; Gaspard N; Hirsch LJ; Fernandez A; Shah SO
JAMA Neurol; 2024 May; 81(5):534-548. PubMed ID: 38466294
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of burst suppression as a predictor of seizure recurrence in refractory status epilepticus.
Fong MWK; Pu K; Jadav R; Khan T; Hirsch LJ; Zaveri HP
Clin Neurophysiol; 2023 Jun; 150():98-105. PubMed ID: 37060844
[TBL] [Abstract][Full Text] [Related]
15. Quantitative burst suppression on serial intermittent EEG in refractory status epilepticus.
Peedicail J; Mehdiratta N; Zhu S; Nedjadrasul P; Ng MC
Clin Neurophysiol Pract; 2021; 6():275-280. PubMed ID: 34825115
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting mortality of refractory status epilepticus.
Tatlidil I; Ture HS; Akhan G
Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
[TBL] [Abstract][Full Text] [Related]
17. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus.
Krishnamurthy KB; Drislane FW
Epilepsia; 1999 Jun; 40(6):759-62. PubMed ID: 10368075
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
Claassen J; Hirsch LJ; Emerson RG; Mayer SA
Epilepsia; 2002 Feb; 43(2):146-53. PubMed ID: 11903460
[TBL] [Abstract][Full Text] [Related]
19. Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment.
Beretta S; Coppo A; Bianchi E; Zanchi C; Carone D; Stabile A; Padovano G; Sulmina E; Grassi A; Bogliun G; Foti G; Ferrarese C; Pesenti A; Beghi E; Avalli L
Neurology; 2018 Dec; 91(23):e2153-e2162. PubMed ID: 30381366
[TBL] [Abstract][Full Text] [Related]
20. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
Dubey D; Bhoi SK; Kalita J; Misra UK
Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
